Inhibiting GS-FDH to Modulate No Bioactivity

Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.

Patents:
AT 510,551   [MORE INFO]

Inventor(s): STAMLER JONATHAN [US]; LIU LIMIN [US]; HAUSLADEN ALFRED [US]; NUDELMAN RAPHAEL [US]

Type of Offer: Licensing



« More Medical Patents

---